Articles

1. Accelerated Drug Development: The Promise Is In The Process 3/21/2012

   In 1993, the FDA issued the call to the pharmaceutical industry to streamline the drug development process from discovery to First In Man. By Jan-Olav Henck, Ph.D., Chief Scientific Officer, Aptuit LLC

2. Brochure: Biologics Contract Manufacturing & Technology Solutions 1/30/2012

   DSM provides turn-key biologic manufacturing solutions, contract manufacturing for preclinical development, clinical trials or commercial supply and reduced cost, risk, and time to market.

3. Maximizing The Success Of Your CRO Partnerships Whitepaper 4/28/2011

   It’s certainly true that pharmaceutical companies are under intense pressure to replenish pipelines and reverse a trend in which R&D returns are falling below the costs of capital.

4. Comprehensive Preclinical Development Program 4/9/2010
   Aptuit was asked to conduct an extended package of preclinical studies within a short time frame. As the critical studies are dependent on the results of earlier work in the package (for example, initiation of the 28 day toxicology studies are dependent on the completion of bioanalytical method development, dose range finding, etc.) not only scheduling, but adherence to the schedule was the major risk to achievement of the overall aim, and on time filing to the regulator. By Aptuit, Inc.